Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 6
2017 4
2018 2
2019 6
2020 5
2021 5
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Nonalcoholic Fatty Liver Disease.
Ding L, Oligschlaeger Y, Shiri-Sverdlov R, Houben T. Ding L, et al. Among authors: oligschlaeger y. Handb Exp Pharmacol. 2022;270:233-269. doi: 10.1007/164_2020_352. Handb Exp Pharmacol. 2022. PMID: 32185502 Review.
Nonalcoholic Fatty Liver Disease.
Ding L, Oligschlaeger Y, Shiri-Sverdlov R, Houben T. Ding L, et al. Among authors: oligschlaeger y. 2020 Mar 18. In: von Eckardstein A, Binder CJ, editors. Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets [Internet]. Cham (CH): Springer; 2022. 2020 Mar 18. In: von Eckardstein A, Binder CJ, editors. Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets [Internet]. Cham (CH): Springer; 2022. PMID: 36122130 Free Books & Documents. Review.
Inflammatory Bowel Disease: A Stressed "Gut/Feeling".
Oligschlaeger Y, Yadati T, Houben T, Condello Oliván CM, Shiri-Sverdlov R. Oligschlaeger Y, et al. Cells. 2019 Jun 30;8(7):659. doi: 10.3390/cells8070659. Cells. 2019. PMID: 31262067 Free PMC article. Review.
Low profile high value target: The role of OxLDL in cancer.
Bitorina AV, Oligschlaeger Y, Shiri-Sverdlov R, Theys J. Bitorina AV, et al. Among authors: oligschlaeger y. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Dec;1864(12):158518. doi: 10.1016/j.bbalip.2019.158518. Epub 2019 Aug 31. Biochim Biophys Acta Mol Cell Biol Lipids. 2019. PMID: 31479734 Free article. Review.
Cathepsin D regulates lipid metabolism in murine steatohepatitis.
Houben T, Oligschlaeger Y, Hendrikx T, Bitorina AV, Walenbergh SMA, van Gorp PJ, Gijbels MJJ, Friedrichs S, Plat J, Schaap FG, Lütjohann D, Hofker MH, Shiri-Sverdlov R. Houben T, et al. Among authors: oligschlaeger y. Sci Rep. 2017 Jun 14;7(1):3494. doi: 10.1038/s41598-017-03796-5. Sci Rep. 2017. PMID: 28615690 Free PMC article.
OxLDL as an Inducer of a Metabolic Shift in Cancer Cells.
Bitorina AV, Oligschlaeger Y, Ding L, Yadati T, Westheim A, Houben T, Vaes RDW, Olde Damink SWM, Theys J, Shiri-Sverdlov R. Bitorina AV, et al. Among authors: oligschlaeger y. J Cancer. 2021 Aug 3;12(19):5817-5824. doi: 10.7150/jca.56307. eCollection 2021. J Cancer. 2021. PMID: 34475995 Free PMC article.
Myosteatosis in NAFLD patients correlates with plasma Cathepsin D.
Ding L, De Munck TJI, Oligschlaeger Y, Dos Reis IM, Verbeek J, Koek GH, Houben T, Shiri-Sverdlov R. Ding L, et al. Among authors: oligschlaeger y. Biomol Concepts. 2021 May 15;12(1):27-35. doi: 10.1515/bmc-2021-0004. Biomol Concepts. 2021. PMID: 33991468 Free article.
29 results